axitinib,sunitinib,pembrolizumab
merck,pfizer
['key,note,42', 'keynote-426', 'kidney cancer', 'key,note,426']
just checked out #sitc member from present the long-term results from the keynote-426 trial of immuno-based combination therapy for kidney cancer at #asco23 . #kidneycancer #cim23 #wearwhite #immune2cancer #sitc23 
Society for Immunotherapy of Cancer (SITC) - Dedicated to improving cancer patient outcomes by advancing the field of tumor immunology and cancer immunotherapy.